Zhi Zhong
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$941KFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $941K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 4, 2021 | NIH | STTR Phase I Treatment of liver fibrosis with oral hepatic stable and non-genotoxic HDAC inhibitors | $350K | Lydex Pharmaceuticals LLC |
| Sep 17, 2019 | NIH | STTR Phase I Next generation HDAC inhibitors with superior potency, selectivity, and pharmacokinetic profiles for the treatment of liver ischemia-reperfusion injury | $295K | Lydex Pharmaceuticals LLC with MEDICAL UNIVERSITY OF SOUTH CAROLINA |
| Sep 16, 2019 | NIH | STTR Phase I Next generation HDAC inhibitors with superior potency, selectivity, and pharmacokinetic profiles for the treatment of liver ischemia-reperfusion injury | $295K | Lydex Pharmaceuticals LLC |
Peer ranks
Federal funding#1,841
Awards as PI#822
Patents#273
Companies
- Lydex Pharmaceuticals LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.